GL1X · GenesisL1 explorer

MolNFT v1 · #69180 · protein

The crystal structures of 2-aminobenzothiazole-based inhibitors in complexes with urokinase-type plasminogen activator

3KID: “The crystal structures of 2-aminobenzothiazole-based inhibitors in complexes with urokinase-type plasminogen…”. X-ray diffraction, 1 ligand (2BS), 1 pocket (best druggability 0.37). MolNFT v1 #69180 on GenesisL1: 3D structure…

PDB
3KID
Type
protein
Length
238 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator
EC
3.4.21.73
UniProt
P00749
Ligands
2BS
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 12% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
UUrokinase-type plasminogen activator (EC 3.4.21.73)protein23812% helix, 39% strandP00749

Ligands and binding sites

  • 2BS · ethyl 2-amino-1,3-benzothiazole-6-carboxylate · ligand · chains U

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1850.370.77262BS

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 3KID · The Crystal Structures of 2-Aminobenzothiazole-based Inhibitors in Complexes with… · the same entry in another collection · chain U against U, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.